Discovery of new low-molecular-weight p53-Mdmx disruptors and their anti-cancer activities

详细信息    查看全文

• 作者：Shinichi Uesato^a ; ^{suesato@gaia.eonet.ne.jp" class="auth_mail" title="E-mail the corresponding author} ; ^{uesato@kansai-u.ac.jp" class="auth_mail" title="E-mail the corresponding author} ; Yoshihiro Matsuura^a ; Saki Matsue^a ; Takaaki Sumiyoshi^a ; Yoshiyuki Hirata^a ; Suzuho Takemoto^a ; Yasuyuki Kawaratani^a ; Yusuke Yamai^a ; Kyoji Ishida^a ; Tsutomu Sasaki^b ; Masato Enari^c ; ^{menari@ncc.go.jp" class="auth_mail" title="E-mail the corresponding author}
• 关键词：o-Aminothiophenol derivative ; p53&ndash ; Mdmx-interaction inhibitor ; Protein&ndash ; protein interaction inhibitor ; Modified ELISA ; GST&ndash ; Mdmx
• 刊名：Bioorganic & Medicinal Chemistry
• 出版年：2016
• 出版时间：15 April 2016
• 年：2016
• 卷：24
• 期：8
• 页码：1919-1926
• 全文大小：1047 K

文摘

Although several p53–Mdm2-binding disruptors have been identified to date, few studies have been published on p53–Mdmx-interaction inhibitors. In the present study, we demonstrated that o-aminothiophenol derivatives with molecular weights of 200–300 selectively inhibited the p53–Mdmx interaction. S-2-Isobutyramidophenyl 2-methylpropanethioate (K-178) (1c) activated p53, up-regulated the expression of its downstream genes such as p21 and Mdm2, and preferentially inhibited the growth of cancer cells with wild-type p53 over those with mutant p53. Furthermore, we found that the S-isobutyryl-deprotected forms 1b and 3b of 1c and S-2-benzamidophenyl 2-methylpropanethioate (K-181) (3c) preferentially inhibited the p53–Mdmx interaction over the p53–Mdm2 interaction, respectively, by using a Flag-p53 and glutathione S-transferase (GST)-fused protein complex (Mdm2, Mdmx, DAPK1, or PPID). In addition, the interaction of p53 with Mdmx was lost by replacing a sulfur atom with an oxygen atom in 1b and 1c. These results suggest that sulfides such as 1b, 3b, 4b, and 5b interfere with the binding of p53–Mdmx, resulting in the dissociation of the two proteins. Furthermore, the results of oral administration experiments using xenografts in nude mice indicated that 1c reduced the volume of tumor masses to 49.0% and 36.6% that of the control at 100 mg/kg and 150 mg/kg, respectively, in 40 days.